stars 1 stars 2 stars 3

Neuron23 Inc. is a clinical-stage biotechnology company focused on developing precision medicines for Parkinson’s disease driven by hyperactive LRRK2. Neuron23 combines advances in human genetics with a state-of-the-art drug discovery and biomarker platform, leveraging advanced techniques in machine learning and artificial intelligence to advance therapeutics aimed at impacting disease progression. The company’s focus is on transforming the future of treatment for PD through innovation, collaboration, and dedication to enhancing patient outcomes. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.

Neuron23 Questions

Arash Rassoulpour is the COO of Neuron23.

18 people are employed at Neuron23.

Neuron23 is based in South San Francisco, California.

Top Neuron23 Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users